Roka Bioscience Company Profile (NASDAQ:ROKA)

About Roka Bioscience (NASDAQ:ROKA)

Roka Bioscience logoRoka Bioscience, Inc. is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

Industry, Sector and Symbol:
  • Sector:
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ROKA
  • CUSIP: N/A
  • Web: www.rokabio.com
Capitalization:
  • Market Cap: $14.82 million
  • Outstanding Shares: 5,007,000
Average Prices:
  • 50 Day Moving Avg: $3.51
  • 200 Day Moving Avg: $4.14
  • 52 Week Range: $2.88 - $16.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.67
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $7.65 million
  • Price / Sales: 1.94
  • Book Value: $5.90 per share
  • Price / Book: 0.50
Profitability:
  • EBIDTA: ($23,260,000.00)
  • Net Margins: -487.61%
  • Return on Equity: -89.22%
  • Return on Assets: -50.43%
Debt:
  • Current Ratio: 2.60%
  • Quick Ratio: 2.36%
Misc:
  • Average Volume: 68,258 shs.
  • Beta: 1.95
  • Short Ratio: 1.98
 

Frequently Asked Questions for Roka Bioscience (NASDAQ:ROKA)

What is Roka Bioscience's stock symbol?

Roka Bioscience trades on the NASDAQ under the ticker symbol "ROKA."

How were Roka Bioscience's earnings last quarter?

Roka Bioscience Inc (NASDAQ:ROKA) released its quarterly earnings data on Thursday, May, 11th. The company reported ($1.53) earnings per share for the quarter, missing the Zacks' consensus estimate of ($1.19) by $0.34. The business earned $2.04 million during the quarter. Roka Bioscience had a negative return on equity of 89.22% and a negative net margin of 487.61%. View Roka Bioscience's Earnings History.

Where is Roka Bioscience's stock going? Where will Roka Bioscience's stock price be in 2017?

1 brokerages have issued twelve-month price objectives for Roka Bioscience's stock. Their predictions range from $10.00 to $10.00. On average, they anticipate Roka Bioscience's share price to reach $10.00 in the next twelve months. View Analyst Ratings for Roka Bioscience.

Who are some of Roka Bioscience's key competitors?

Who are Roka Bioscience's key executives?

Roka Bioscience's management team includes the folowing people:

  • Paul G. Thomas, Chairman of the Board
  • Mary Duseau, President, Chief Executive Officer, Secretary, Director
  • Lars Boesgaard, Chief Financial Officer
  • Nicholas J. Valeriani, Director
  • Fred E. Cohen Ph.D., M.D., Independent Director
  • Michael P. Doyle Ph.D., Independent Director
  • David W. J. McGirr, Independent Director
  • Jonathan Todd Silverstein, Independent Director

Who owns Roka Bioscience stock?

Roka Bioscience's stock is owned by many different of institutional and retail investors. Top institutional investors include NEA Management Company LLC (17.84%), TPG Group Holdings SBS Advisors Inc. (17.38%) and Sabby Management LLC (7.77%). View Institutional Ownership Trends for Roka Bioscience.

Who bought Roka Bioscience stock? Who is buying Roka Bioscience stock?

Roka Bioscience's stock was acquired by a variety of institutional investors in the last quarter, including Sabby Management LLC. View Insider Buying and Selling for Roka Bioscience.

How do I buy Roka Bioscience stock?

Shares of Roka Bioscience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Roka Bioscience's stock price today?

One share of Roka Bioscience stock can currently be purchased for approximately $2.96.


MarketBeat Community Rating for Roka Bioscience (NASDAQ ROKA)
Community Ranking:  2.1 out of 5 ( )
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  94
MarketBeat's community ratings are surveys of what our community members think about Roka Bioscience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Roka Bioscience (NASDAQ:ROKA) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (237.84% upside)

Analysts' Ratings History for Roka Bioscience (NASDAQ:ROKA)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/12/2016Roth CapitalInitiated CoverageBuy$10.00N/AView Rating Details
3/6/2016Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
11/12/2015WedbushLower Price TargetNeutral$3.00 -> $2.00N/AView Rating Details
(Data available from 5/30/2015 forward)

Earnings

Earnings History for Roka Bioscience (NASDAQ:ROKA)
Earnings by Quarter for Roka Bioscience (NASDAQ:ROKA)
Earnings History by Quarter for Roka Bioscience (NASDAQ ROKA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/11/2017Q1 2017($1.19)($1.53)$2.04 millionViewN/AView Earnings Details
11/7/2016Q316($5.39)$1.50 million$1.90 millionViewListenView Earnings Details
5/4/2016Q116($0.46)($0.47)$1.56 million$1.60 millionViewN/AView Earnings Details
3/4/2016Q415($0.48)($0.56)$1.63 million$1.50 millionViewN/AView Earnings Details
11/11/2015Q315($0.53)($0.49)$1.75 million$1.50 millionViewN/AView Earnings Details
8/13/2015Q215($0.51)($0.54)$1.58 million$1.50 millionViewN/AView Earnings Details
5/7/2015Q115($0.50)($0.51)$1.44 million$1.51 millionViewN/AView Earnings Details
3/26/2015Q414($0.52)($0.43)$1.44 million$1.36 millionViewN/AView Earnings Details
11/6/2014($0.49)($0.64)$2.11 million$1.48 millionViewN/AView Earnings Details
8/11/2014Q214($11.28)$1.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Roka Bioscience (NASDAQ:ROKA)
2017 EPS Consensus Estimate: ($4.44)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($1.19)($1.19)($1.19)
Q2 20171($1.14)($1.14)($1.14)
Q3 20171($1.08)($1.08)($1.08)
Q4 20171($1.03)($1.03)($1.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Roka Bioscience (NASDAQ:ROKA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Roka Bioscience (NASDAQ:ROKA)
Insider Ownership Percentage: 28.90%
Insider Trades by Quarter for Roka Bioscience (NASDAQ:ROKA)
Institutional Ownership by Quarter for Roka Bioscience (NASDAQ:ROKA)
Insider Trades by Quarter for Roka Bioscience (NASDAQ:ROKA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/17/2014David W J McgirrDirectorBuy50,000$3.60$180,000.00View SEC Filing  
7/22/2014Patrick J KerinsMajor ShareholderBuy383,333$12.00$4,599,996.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Roka Bioscience (NASDAQ:ROKA)
Latest Headlines for Roka Bioscience (NASDAQ:ROKA)
Source:
DateHeadline
finance.yahoo.com logoRoka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 8:01 PM
finance.yahoo.com logoEdited Transcript of ROKA earnings conference call or presentation 11-May-17 8:30pm GMT
finance.yahoo.com - May 12 at 10:50 PM
americanbankingnews.com logoRoka Bioscience Inc (ROKA) Issues Quarterly Earnings Results
www.americanbankingnews.com - May 12 at 12:14 PM
finance.yahoo.com logoInvestor Network: Roka Bioscience Inc to Host Earnings Call
finance.yahoo.com - May 11 at 8:03 PM
finance.yahoo.com logoRoka Bioscience Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 11 at 8:03 PM
streetinsider.com logoRoka Bioscience (ROKA) Enters Distribution Partnership with FoodChek Systems
www.streetinsider.com - May 9 at 10:45 AM
reuters.com logoBRIEF-Roka Bioscience says entered into 5-year non-exclusive distribution agreement with Foodchek Systems Inc
www.reuters.com - May 9 at 10:45 AM
finance.yahoo.com logoRoka Bioscience, Inc. Announces Distribution Partnership with FoodChek Systems Inc.
finance.yahoo.com - May 8 at 6:55 PM
finance.yahoo.com logoRoka Bioscience to Report First Quarter 2017 Financial Results on May 11, 2017
finance.yahoo.com - May 4 at 7:50 PM
americanbankingnews.com logoSomewhat Negative Press Coverage Extremely Likely to Impact Roka Bioscience (ROKA) Stock Price
www.americanbankingnews.com - May 4 at 1:42 PM
finance.yahoo.com logoRoka Bioscience to Present and Exhibit at the 2017 Food Safety Summit
finance.yahoo.com - May 2 at 5:24 PM
globenewswire.com logoFood Safety Testing Market Size to Reach USD 8.04 Billion by 2021: Zion Market Research
globenewswire.com - April 28 at 3:44 PM
americanbankingnews.com logoSomewhat Positive News Coverage Likely to Affect Roka Bioscience (ROKA) Share Price
www.americanbankingnews.com - April 27 at 9:58 PM
americanbankingnews.com logoRoka Bioscience Inc (ROKA) Short Interest Down 7.8% in April
www.americanbankingnews.com - April 26 at 5:32 PM
americanbankingnews.com logoRoka Bioscience (ROKA) Earning Somewhat Favorable Press Coverage, Study Finds
www.americanbankingnews.com - April 14 at 10:23 PM
prnewswire.com logoRoka Bioscience to participate in the 40th Annual National Food Policy Conference - PR Newswire (press release)
www.prnewswire.com - April 11 at 9:57 AM
finance.yahoo.com logoRoka Bioscience to participate in the 40th Annual National Food Policy Conference
finance.yahoo.com - April 10 at 7:07 PM
finance.yahoo.com logoRoka Bioscience to Present at the Sidoti & Company Spring 2017 Convention
finance.yahoo.com - March 28 at 7:25 AM
capitalcube.com logoRoka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 24, 2017
us.rd.yahoo.com - March 24 at 7:25 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 20 at 5:40 PM
finance.yahoo.com logoRoka Bioscience to Present at the 29th Annual Roth Conference
finance.yahoo.com - March 10 at 10:16 PM
us.rd.yahoo.com logoRoka Bioscience Reports Fourth Quarter and Full Year 2016 Financial Results
us.rd.yahoo.com - March 9 at 7:34 PM
biz.yahoo.com logoQ4 2016 Roka Bioscience Inc Earnings Release - After Market Close
biz.yahoo.com - March 9 at 8:09 AM
finance.yahoo.com logoRoka Bioscience to Report Fourth Quarter and Full Year 2016 Financial Results
finance.yahoo.com - March 2 at 7:43 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements a
biz.yahoo.com - March 1 at 10:13 AM
finance.yahoo.com logoRoka Bioscience To Exhibit And Present At IPPE 2017 Poultry Expo
finance.yahoo.com - January 26 at 3:59 AM
us.rd.yahoo.com logo4:16 pm Roka Bioscience appoints Mary Duseau as President and CEO effective today
us.rd.yahoo.com - January 18 at 12:58 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
biz.yahoo.com - January 17 at 7:56 PM
finance.yahoo.com logoCoverage initiated on Roka Bioscience by ROTH Capital
finance.yahoo.com - December 13 at 8:00 PM
finance.yahoo.com logoROKA BIOSCIENCE, INC. Financials
finance.yahoo.com - November 16 at 7:31 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - November 8 at 7:01 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - November 7 at 8:01 PM
biz.yahoo.com logoQ3 2016 Roka Bioscience Inc Earnings Release - After Market Close
biz.yahoo.com - November 7 at 11:09 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - November 1 at 7:25 PM
benzinga.com logoRoka Bioscience to Report Third Quarter 2016...
www.benzinga.com - October 31 at 6:56 PM
finanznachrichten.de logoLeading Subject Matter Experts Will Address Key Issues and Solutions at Food Safety Summit Resource Center at PACK EXPO
www.finanznachrichten.de - October 27 at 7:13 PM
streetinsider.com logoRoka Bioscience (ROKA) to Effect 1-for-10 Reverse Stock Split
www.streetinsider.com - October 12 at 7:02 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
biz.yahoo.com - October 11 at 7:26 PM
finance.yahoo.com logoRoka Bioscience, Inc. to present at The MicroCap Conference on October 24-25 in Philadelphia
finance.yahoo.com - October 11 at 7:26 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec
biz.yahoo.com - September 22 at 11:55 AM
streetinsider.com logoRoka Bioscience (ROKA) Prices $22.5M Series A Preferred Stock Private Placement
www.streetinsider.com - September 18 at 11:17 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi
biz.yahoo.com - September 16 at 6:51 PM
finance.yahoo.com logo9:03 am Roka Bioscience enters into $22.5 mln private placement of approx. 22,500 shares of its Series A Preferred Stock
finance.yahoo.com - September 16 at 10:39 AM

Social

Chart

Roka Bioscience (ROKA) Chart for Tuesday, May, 30, 2017

This page was last updated on 5/30/2017 by MarketBeat.com Staff